Saturday, 12 May 2012
Joint Venture with Bangalore Headquartered Manipal Group Leverages Mobile Health Revolution in India to Commercialize Everist’s New Cardiovascular Diagnostics
ANN ARBOR, Mich, May 22, 2012 – Everist Health , a rapidly growing personalized medicine company, announced today that it has established a joint-venture company with the Manipal Group, one of the three largest healthcare sector companies in India. The joint venture will market EGI’s portfolio of diagnostic, prognostic and therapeutic selection technologies in India. Over 350 cardiologists attended a medical conference organized by one of India’s leading cardiac centers, Medanta Hospital in Delhi, at which EGI’s two new mobile health (mHealth) diagnostic systems for cardiovascular disease, AngioDefender and CardioDefender were introduced to physicians attending the conference. Over 300 physicians registered on a waiting list to receive EGI’s devices as they become available in India.
AngioDefender and CardioDefender integrate novel sensor technology with mobile digital services, smartphones and other mobile devices to provide flexible monitoring and diagnosis of cardiovascular conditions that traditionally have been limited to observation through legacy hospital diagnostic systems.
Monday, 13 February 2012
– Genome Sequencing Pioneer Dr. J. Craig Venter to Deliver Keynote Speech at Gala Dinner –
ANN ARBOR, Mich, February 13, 2012 – Everist Health, a rapidly growing personalized medicine company, today announced that world-renowned scientist and genome sequencing pioneer Dr. J. Craig Venter will be the keynote speaker for its March 26th Gala Dinner at the Field Museum in Chicago.